Back to search

Article

mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2

2021-12-29

Abstract excerpt

<h4>ABSTRACT</h4> Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019, viral variants with greater transmissibility or immune evasion properties have arisen, which could jeopardize recently deployed vaccine and antibody-based countermeasures. Here, we evaluated in mice and hamsters the efficacy of preclinical non-GMP Moderna mRNA vaccine (mRNA-1273) and the Johnson & Johnso...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ddde3c7-062a-5140-8687-e631c6d060d0
DOI
10.1101/2021.12.29.474432
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2DOI 10.1101/2021.12.29.474432
Select a neighboring publication to make it the new centre.